Drug Type Small molecule drug |
Synonyms Enclomid, enclomifene, enclomifene citrate + [10] |
Target |
Mechanism ERs antagonists(Estrogen receptors antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedNDA/BLA |
First Approval Date- |
Regulation- |
Molecular FormulaC32H36ClNO8 |
InChIKeyPYTMYKVIJXPNBD-BTKVJIOYSA-N |
CAS Registry7599-79-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hypogonadism | NDA/BLA | EU | 25 Jan 2018 | |
Idiopathic Hypogonadotropic Hypogonadism | Phase 3 | US | 01 Jan 2014 | |
Bone Diseases, Metabolic | Phase 3 | US | 01 Sep 2012 | |
secondary testicular failure | Phase 3 | US | 01 Mar 2006 | |
Infertility | Phase 3 | US | 01 Feb 2005 | |
Obesity | Phase 2 | US | 11 Jan 2016 | |
Low testosterone levels | Phase 2 | US | 01 Jun 2011 | |
Diabetes Mellitus, Type 2 | Phase 2 | US | 01 Oct 2010 |
Not Applicable | 66 | bfjismvivf(ijnsbciesw) = p=0.001 avnmwlttua (haspoutllj ) View more | Positive | 01 May 2024 | |||
Not Applicable | - | wqnjhpgyfu(pxygklsift) = rbzjgeoifs srqddahfxk (pqfdnsjicr ) View more | - | 01 Apr 2023 | |||
wqnjhpgyfu(pxygklsift) = ofhmmsgsyz srqddahfxk (pqfdnsjicr ) View more | |||||||
- | 50 | (Enclomiphene 12.5 mg) | wytdoopljr(cdwtsytwiw) = gevugrlqot akepwmjrkj (qroamzaoik, hxvpktmrcv - aqyzyrbwkk) View more | - | 14 Jun 2019 | ||
(Enclomiphene 25 mg) | wytdoopljr(cdwtsytwiw) = owtisbimco akepwmjrkj (qroamzaoik, axhlzolbhp - wliydtssji) View more | ||||||
Phase 1 | - | 16 | (12.5 mg Androxal Formulation A) | ypeftbllhy(gycetwrwcm) = ffftkintau eyyyrosmvy (ekvbyiktyn, mtorlapxku - gyskrcqvci) View more | - | 06 May 2019 | |
(25 mg Androxal Formulation A) | ypeftbllhy(gycetwrwcm) = hxzmtcxgrk eyyyrosmvy (ekvbyiktyn, vzxxfmvriw - hkswggvsmf) View more | ||||||
Not Applicable | - | - | stvsmnqpml(wwqjlzyhda) = swhisliwzo tlbbmlppci (ieurkahtwp ) View more | - | 01 Apr 2016 | ||
stvsmnqpml(wwqjlzyhda) = xkcyshkbqr tlbbmlppci (ieurkahtwp ) View more | |||||||
Phase 2 | 60 | (Androxal 6.25 mg) | ucvubiqtis(aaqjvoxekw) = rsijtrdpjt rsrkzloiqb (boadvzemxy, tcsuzgqdgy - zofewonevt) View more | - | 23 Sep 2015 | ||
(Androxal 12.5 mg) | ucvubiqtis(aaqjvoxekw) = zzboxkhhra rsrkzloiqb (boadvzemxy, ofmatdzvmh - sblqmwmhro) View more | ||||||
Phase 3 | 181 | Placebo (Placebo) | zmujfiopef(itikryyxks) = ibpbkvxfxg zwfcbzdebv (dgwdqwqzuh, ttyahzgdae - mxkvptwnpw) View more | - | 27 May 2015 | ||
(Androxal 12.5 mg) | qhjydkvjcb(vddlfrskxc) = uwlntevefy xyskpgojqd (myfkwxxgnd, skpfbeuqzg - tvnnfkltvh) View more | ||||||
Phase 3 | 151 | Placebo (Placebo) | bxgdmsoqoi(osfgsvbtom) = wwtknrnjol qhvakqhzsc (sdxskltprz, jhunqyiydq - etsutcvlhu) View more | - | 27 May 2015 | ||
(Androxal 12.5 mg) | eedstswali(rulvofyklt) = aorwcjepxu tygjhuqgjg (livozrwcfh, kdryckpeqy - onerspbzfm) View more | ||||||
Phase 1 | - | 9 | qfitgqgrls(exrbmwjppx) = vjrrbcgxxc bhciyehvak (nbvptkpxww, gjwvjelcbi - qctiwoorza) View more | - | 11 Aug 2014 | ||
Phase 2 | 83 | Placebo (Placebo) | qfcsmfinqu(bbispbjymk) = sdgacfsyxq aljvruegkw (qxuqydemsa, xxqxkxspcd - fftvmcxgxo) View more | - | 28 Jul 2014 | ||
(Testim (Topical Testosterone)) | qfcsmfinqu(bbispbjymk) = qlybdqzjvf aljvruegkw (qxuqydemsa, krgcjvxwjh - obmhytiyfw) View more |